Nonalcoholic Fatty liver disease.
Nonalcoholic fatty liver disease is a condition gaining increasing recognition as a cause of cirrhosis and end-stage liver disease. The condition appears identical to alcoholic liver disease histologically, yet occurs in patients with negligible alcohol intake. Nonalcoholic fatty liver disease covers a spectrum of diseases ranging from simple fatty deposition in the liver to fat and inflammation and finally to fibrosis and cirrhosis. Conditions most frequently found in association with nonalcoholic fatty liver disease include obesity, Type 2 diabetes, and hyperlipidemia. Although the exact etiology of nonalcoholic fatty liver disease is not clear, insulin resistance is thought to play an important factor. Patients typically present with asymptomatic serum aminotransferase elevations of 2-3 times normal. Symptoms may include fatigue and abdominal pain. The clinical course is difficult to predict due to a lack of research in the natural history of the disease. It is known a percentage of patients progress to end-stage liver disease and may require liver transplantation. No medical treatment has been found to be totally effective. Patients who are overweight or obese should be encouraged in gradual weight reduction that has been associated with improvement in liver test abnormalities.
Jorgensen
Roberta A
RA
Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN 44905, USA. Jorgensen.Roberta@mayo.edu
D000428:Alcohol Drinking; D048909:Diabetes Complications; D018450:Disease Progression; D005234:Fatty Liver / Q000209:etiology / Q000451:nursing* / Q000503:physiopathology*; D005355:Fibrosis / Q000473:pathology; D006801:Humans; D009765:Obesity / Q000150:complications